Brought to you by 
Lilly and Jubilant form JV; Jubilant later takes over
30 Jan 2012
Executive Summary
Eli Lilly and Jubilant Organosys (drug discovery, research, and manufacturing services; based in India) have agreed to form a 50/50 joint venture for the development of new drugs across various therapy areas.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Joint Venture
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com